TIDMMYX

MyCelx Technologies Corporation

24 January 2023

24 January 2023

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

Rental Contract Secured for PFAS Remediation System at Landfill

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company, is pleased to announce that it has secured a paid 6-month trial for treatment of PFAS in the United States. PFAS, which stands for per-fluoroalkyl and poly-fluoroalkyl compounds, are a collection of long-lasting manmade toxic chemicals which present a global threat to human health and the environment.

MYCELX has secured a contract for its fully containerized, mobile PFAS remediation system which includes MYCELX infused cartridge filtration and Performer(TM) media. The system will be utilized for treating PFAS contaminated leachate from a solid waste landfill. The rental is expected to successfully demonstrate the ability of the proprietary MYCELX technology to completely remove all identified PFAS chemicals to non-detectable concentrations in a single pass.

The revenue from this trial is not anticipated to alter management's revenue expectations for the year.

Connie Mixon, CEO, commented:

"We are pleased to announce this promising paid trial. The award is further proof of the strong momentum we are generating as a business in the PFAS solutions market, building on the Company's success with its previous trial in America and installations in Australia with an important distributor. In addition, in scenarios of solid waste landfill, we continue to see a growing demand for technologies that are able to treat the co-contaminants that are present with PFAS.

As a Group, we are firmly focused on achieving greater market share in three core areas; the Middle East, PFAS and REGEN. All of which we believe will be key growth drivers for MYCELX in 2023. We look forward to updating all our stakeholders on further corporate developments over the coming months."

For further information, please contact:

 
MYCELX Technologies Corporation 
 Connie Mixon, CEO                                   Tel: +1 888 306 6843 
 Kim Slayton, CFO 
Canaccord Genuity Limited (Nomad and Sole Broker) 
 Henry Fitzgerald-O'Connor                           Tel: +44 20 7523 8000 
 Gordon Hamilton 
Celicourt Communications (Financial PR) 
 Mark Antelme                                        Tel: +44 20 8434 2754 
 Jimmy Lea

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRANKNBKCBKDQDB

(END) Dow Jones Newswires

January 24, 2023 02:00 ET (07:00 GMT)

Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Mycelx Technologies Charts.
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Mycelx Technologies Charts.